Compare GH & OVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GH | OVV |
|---|---|---|
| Founded | 2011 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 14.0B |
| IPO Year | 2018 | 2019 |
| Metric | GH | OVV |
|---|---|---|
| Price | $78.81 | $56.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 17 |
| Target Price | ★ $120.05 | $58.24 |
| AVG Volume (30 Days) | 1.7M | ★ 3.8M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.14% |
| EPS Growth | 6.74 | ★ 13.54 |
| EPS | N/A | ★ 4.78 |
| Revenue | $982,021,000.00 | ★ $8,908,000,000.00 |
| Revenue This Year | $33.30 | $3.41 |
| Revenue Next Year | $28.19 | N/A |
| P/E Ratio | ★ N/A | $11.72 |
| Revenue Growth | ★ 32.88 | N/A |
| 52 Week Low | $36.36 | $31.90 |
| 52 Week High | $120.74 | $62.60 |
| Indicator | GH | OVV |
|---|---|---|
| Relative Strength Index (RSI) | 35.40 | 48.95 |
| Support Level | $54.39 | $37.18 |
| Resistance Level | $114.53 | $62.60 |
| Average True Range (ATR) | 5.45 | 1.94 |
| MACD | 0.07 | -0.77 |
| Stochastic Oscillator | 16.18 | 8.14 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Ovintiv Inc is a North American oil and natural gas exploration and production company focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs, and natural gas. The company has two operating segments: USA Operations and Canadian Operations. USA Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within the United States. Canadian Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within Canada. The company generates the majority of its revenue from USA Operations.